title: Acute ST-elevation inferior myocardial infarction in a patient with a non-obstructive mechanical mitral valve thrombosis.
abstract: The risk of systemic embolisation in patients with prosthetic heart valves who are receiving anticoagulation therapy is 0.5 to 1.7% per patient year and most cases present with cerebrovascular events. Here we report the case of a 42-year-old woman who was uneventfully treated with a low dose, prolonged infusion of tissue plasminogen activator because of non-obstructive prosthetic mitral valve thrombosis. It presented as coronary embolism and resulted in acute ST-elevation inferior myocardial infarction.
authors.affiliation: Department of Cardiology, Kosuyolu Kartal Heart Training and Educational Hospital, Istanbul, Turkey. ahmetaykan@yahoo.com
authors.forename: Ahmet Cagri
authors.initials: AC
authors.lastname: Aykan
authors.forename: Mehmet
authors.initials: M
authors.lastname: Ozkan
authors.forename: Nilufer Eksi
authors.initials: NE
authors.lastname: Duran
authors.forename: Mustafa
authors.initials: M
authors.lastname: Yildiz
mesh_terms: D000328:Adult; D017023:Coronary Angiography; D003328:Coronary Thrombosis / Q000139:chemically induced / Q000175:diagnosis* / Q000503:physiopathology; D054796:Drug Dosage Calculations; D017548:Echocardiography, Transesophageal; D004562:Electrocardiography; D005260:Female; D019918:Heart Valve Prosthesis Implantation; D006801:Humans; D008943:Mitral Valve / Q000000981:diagnostic imaging / Q000601:surgery; D058386:Mitral Valve Annuloplasty; D009203:Myocardial Infarction / Q000139:chemically induced / Q000175:diagnosis* / Q000503:physiopathology; D011183:Postoperative Complications / Q000175:diagnosis* / Q000503:physiopathology; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D010959:Tissue Plasminogen Activator